This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Uulke van der Heide group


Uulke van der Heide

Group leader, Professor at Leiden UMC

Personal details


Uulke van der Heide received his PhD degree (cum laude) in the field of molecular biophysics from the Utrecht University in 1993. He subsequently worked as a post-doc at the physiology departments of the University Medical Center in Utrecht and at the University of Pennsylvania in Philadelphia, US, on the molecular mechanism of motor proteins.

In 1999 he moved to the field of radiation oncology, as a resident medical physicist at the University Medical Center in Utrecht. He got his license in 2003. Between 2003 and 2011 he worked as a medical physicist and researcher in the same department, working on MRI-guided radiotherapy, focussing on prostate cancer. Together with Marco van Vulpen he initiated the phase III FLAME trial for focal boosting of prostate cancer.

In 2011 he moved to the Netherlands Cancer Institute as a medical physicist and group leader, working on MRI-guided radiotherapy. In this capacity he is project leader of the MR-Linac project. His research focusses on quantitative MRI techniques for tumor characterization and response monitoring of radiotherapy. In August 2015 he was appointed professor of imaging technology in radiation oncology at the Leiden University Medical Center.

Share this page